Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mind Medicine (MindMed) Inc. - Common Shares (NQ: MNMD )

9.890 +1.240 (+14.34%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
32 33 Next >
MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes
MindMed (NASDAQ: MNMD), which recently received a letter on behalf of one of its shareholders calling for a new business strategy and offer 
Via Benzinga
Mind Medicine, Numinus Wellness Among Top Psychedelic Movers From Today
  
Via Benzinga
Compass Pathways, Revive Therapeutics Among Top Psychedelic Movers Of Today
  
Via Benzinga
What's Going On With MindMed? Co-Founder Dr. Scott Freeman Lays Out 'Value Enhancement Plan'
FCM MM Holdings sent a letter to MindMed’s (NASDAQ: MNMD) board of directors calling on them to adopt a new strategic plan to "turn the company around.” 
Via Benzinga
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
Psychedelic Stock Gainers And Losers From August 10, 2022
  
Via Benzinga
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study... 
Via FinancialNewsMedia
Topics Supply Chain
Exposures Supply Chain
3 Best Psychedelic Stocks to Buy Now
These are three of the best psychedelic stocks to buy to get in on the next generation of treatment for mental health disorders. 
Via InvestorPlace
Cybin, Field Trip Health Among Top Psychedelic Movers Of Today
  
Via Benzinga
GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 29.83% at $15.80 
Via Benzinga
Key Biotech Company Goes All The Way To Reverse Share Split, Here's What We Know
Psychedelics appear to be here to stay. Yet stocks, shares and finance are another story. On August 4, publicly traded clinical-stage psychedelics firm Mind Medicine Inc. 
Via Benzinga
Psychedelic Stock Gainers And Losers From August 4, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 10.64% at $12.17 
Via Benzinga
ATAI Life Sciences, Allied Among Top Psychedelic Movers Of Today
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.61% at $3.82 
Via Benzinga
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 4.95% at $0.34 
Via Benzinga
July Update: Psychedelic Compounds-Based Drug Stocks Index Up 23%; Remains Down 44% YTD
Of the 107 clinical-stage psychedelic drug stocks trading on North American stock exchanges only 8 have market caps of $50M or more, and trade for US$0.50/share or more. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From July 29, 2022
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.30% at $0.22 
Via Benzinga
Allied, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 19.46% at $0.55 
Via Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 5.66% at $16.06 
Via Benzinga
Allied, GH Research Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 22.11% at $0.55 
Via Benzinga
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 2.76% at $14.91 LOSERS: 
Via Benzinga
Psychedelic Stock Gainers And Losers From July 22, 2022
GAINERS: Allied (OTC:ALID) shares closed up 11.04% at $0.50 
Via Benzinga
Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today
GAINERS: LOSERS: Allied (OTC:ALID) shares closed down 10.00% at $0.45 
Via Benzinga
Dear Psychedelic Stocks Fans, Watch This Key Catalyst
Psychedelic stocks are in focus following new legislation from both the Senate and the House that has bipartisan support. 
Via InvestorPlace
7 Best Pharmaceutical Stocks to Buy Now
These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world. 
Via InvestorPlace
Psychedelic Stock Gainers And Losers From July 20, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 10.53% at $15.11 
Via Benzinga
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 8.09% at $0.93 
Via Benzinga
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 7.69% at $13.02 
Via Benzinga
The 8 Largest Psychedelic Compounds-Based Drug Stocks: A Financial Assessment
A look at the stock performances of the 8 largest clinical-stage companies involved in the research and development of psychedelic compound-based drugs. 
Via Talk Markets
Awakn Life Sciences Receives Funding From UK Government To Identify Most Efficient Go-To-Market Pathway For Proprietary Ketamine-Assisted Therapy
Awakn Life Sciences Corp. (OTCQB: AWKNF) reported it secured funding from Innovate UK to identify the quickest and most cost-effective route to market in both the U.K. and the U.S. 
Via Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 7.05% at $0.52 
Via Benzinga
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.